|
Volumn 13, Issue 3, 2003, Pages 187-194
|
Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-kappaB and AP-1.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLIN DEPENDENT KINASE 1;
DOXYCYCLINE;
EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS;
EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS;
HYBRID PROTEIN;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
LUCIFERASE;
MATRIX PROTEIN;
PROTEIN P53;
TRANSCRIPTION FACTOR AP 1;
ARTICLE;
CELL CYCLE;
CELL CYCLE G2 PHASE;
CELL DIVISION;
DOSE RESPONSE;
DRUG EFFECT;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
METABOLISM;
MITOSIS;
NASOPHARYNX TUMOR;
PATHOLOGY;
TUMOR CELL LINE;
WESTERN BLOTTING;
BLOTTING, WESTERN;
CDC2 PROTEIN KINASE;
CELL CYCLE;
CELL DIVISION;
CELL LINE, TUMOR;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOXYCYCLINE;
G2 PHASE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
LUCIFERASES;
MITOSIS;
NASOPHARYNGEAL NEOPLASMS;
NF-KAPPA B;
RECOMBINANT FUSION PROTEINS;
TRANSCRIPTION FACTOR AP-1;
TUMOR SUPPRESSOR PROTEIN P53;
VIRAL MATRIX PROTEINS;
|
EID: 1542646971
PISSN: 10010602
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.cr.7290163 Document Type: Article |
Times cited : (42)
|
References (0)
|